Phase 3, randomized control trial (n=24,966) for single dose RSV vaccine (RSVPreF3 OA) was shown to be highly efficacious against severe disease and infection in older adults (60+) regardless of RSV subtype - discu.eu

Reddit

Phase 3, randomized control trial (n=24,966) for single dose RSV vaccine (RSVPreF3 OA) was shown to be highly efficacious against severe disease and infection in older adults (60+) regardless of RSV subtype https://www.nejm.org/doi/full/10.1056/NEJMoa2209604 4 comments 19/2/2023 science